Cargando…
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor antagonist, represents an emerging therapeutic option. We report two cases of children, diagnosed with...
Autores principales: | Mastrolia, Maria Vincenza, Abbati, Giulia, Signorino, Claudia, Maccora, Ilaria, Marrani, Edoardo, Pagnini, Ilaria, Simonini, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010843/ https://www.ncbi.nlm.nih.gov/pubmed/33854568 http://dx.doi.org/10.1177/1759720X211002593 |
Ejemplares similares
-
Neuro-PIMS-TS: a single case report and review of the literature
por: Scarcella, Antonio, et al.
Publicado: (2022) -
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment
por: Mastrolia, Maria Vincenza, et al.
Publicado: (2021) -
A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review
por: Maccora, Ilaria, et al.
Publicado: (2023) -
The off-label use of anakinra in pediatric systemic autoinflammatory diseases
por: Maniscalco, Valerio, et al.
Publicado: (2020) -
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?
por: Pagnini, Ilaria, et al.
Publicado: (2021)